EP1552012A4 - PREDISPOSITION GENE FOR ATTACK IN HUMANS AND METHODS OF TREATMENT - Google Patents
PREDISPOSITION GENE FOR ATTACK IN HUMANS AND METHODS OF TREATMENTInfo
- Publication number
- EP1552012A4 EP1552012A4 EP03770392A EP03770392A EP1552012A4 EP 1552012 A4 EP1552012 A4 EP 1552012A4 EP 03770392 A EP03770392 A EP 03770392A EP 03770392 A EP03770392 A EP 03770392A EP 1552012 A4 EP1552012 A4 EP 1552012A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- methods
- susceptibility gene
- human stroke
- stroke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US650120 | 1996-06-03 | ||
US255120 | 2002-09-25 | ||
US10/255,120 US20040091865A1 (en) | 2001-03-19 | 2002-09-25 | Human stroke gene |
US419723 | 2003-04-18 | ||
US10/419,723 US20040014099A1 (en) | 2001-03-19 | 2003-04-18 | Susceptibility gene for human stroke; methods of treatment |
US65012003A | 2003-08-27 | 2003-08-27 | |
PCT/US2003/029906 WO2004028341A2 (en) | 2001-03-19 | 2003-09-25 | Susceptibility gene for human stroke; methods of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1552012A2 EP1552012A2 (en) | 2005-07-13 |
EP1552012A4 true EP1552012A4 (en) | 2006-06-07 |
Family
ID=56290488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03770392A Withdrawn EP1552012A4 (en) | 2002-09-25 | 2003-09-25 | PREDISPOSITION GENE FOR ATTACK IN HUMANS AND METHODS OF TREATMENT |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1552012A4 (ja) |
JP (1) | JP2006500068A (ja) |
AU (1) | AU2003278877A1 (ja) |
CA (1) | CA2499320A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109298133B (zh) * | 2018-07-18 | 2021-07-13 | 重庆邮电大学 | 基于边缘通道校正的探测器模块生产良品率改进方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000023091A2 (en) * | 1998-10-15 | 2000-04-27 | Bioimage A/S | Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
WO2000040714A2 (en) * | 1998-12-30 | 2000-07-13 | Oligos Etc. Inc. | Therapeutic phosphodiesterase inhibitors |
WO2001000851A1 (en) * | 1999-06-25 | 2001-01-04 | Memory Pharmaceutical Corporation | Cyclic amp phosphodiesterase isoforms and methods of use |
WO2002074992A2 (en) * | 2001-03-19 | 2002-09-26 | Decode Genetics Ehf. | Phosphodiesterase 4d genes related to human stroke |
-
2003
- 2003-09-25 EP EP03770392A patent/EP1552012A4/en not_active Withdrawn
- 2003-09-25 AU AU2003278877A patent/AU2003278877A1/en not_active Abandoned
- 2003-09-25 JP JP2004540173A patent/JP2006500068A/ja active Pending
- 2003-09-25 CA CA002499320A patent/CA2499320A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000023091A2 (en) * | 1998-10-15 | 2000-04-27 | Bioimage A/S | Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
WO2000040714A2 (en) * | 1998-12-30 | 2000-07-13 | Oligos Etc. Inc. | Therapeutic phosphodiesterase inhibitors |
WO2001000851A1 (en) * | 1999-06-25 | 2001-01-04 | Memory Pharmaceutical Corporation | Cyclic amp phosphodiesterase isoforms and methods of use |
WO2002074992A2 (en) * | 2001-03-19 | 2002-09-26 | Decode Genetics Ehf. | Phosphodiesterase 4d genes related to human stroke |
Non-Patent Citations (5)
Title |
---|
GRAEME B BOLGER ET AL: "Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, vol. 328, 1997, pages 539 - 548, XP002150449, ISSN: 0264-6021 * |
GRETARSDOTTIR SOLVEIG ET AL: "Localization of a susceptibility gene for common forms of stroke to 5q12", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 70, no. 3, March 2002 (2002-03-01), pages 593 - 603, XP002376109, ISSN: 0002-9297 * |
GRETARSDOTTIR SOLVEIG ET AL: "The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.", NATURE GENETICS, vol. 35, no. 2, October 2003 (2003-10-01), pages 131 - 138, XP002376110, ISSN: 1061-4036 * |
KOSTIC M M ET AL: "Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, vol. 29, no. 11, November 1997 (1997-11-01), pages 3135 - 3146, XP002278927, ISSN: 0022-2828 * |
PEREZ-TORRES S ET AL: "Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and (3H)rolipram binding autoradiography comparison with monkey and rat brain", JOURNAL OF CHEMICAL NEUROANATOMY, CHICHESTER, GB, vol. 20, no. 3-4, December 2000 (2000-12-01), pages 349 - 374, XP002275597, ISSN: 0891-0618 * |
Also Published As
Publication number | Publication date |
---|---|
JP2006500068A (ja) | 2006-01-05 |
AU2003278877A8 (en) | 2004-04-19 |
CA2499320A1 (en) | 2004-04-08 |
EP1552012A2 (en) | 2005-07-13 |
AU2003278877A1 (en) | 2004-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301347A8 (en) | Methods for monitoring treatment of disease | |
IL174175A0 (en) | Methods of treating autoimmune diseases using il-21 | |
IL162201A0 (en) | New methods for diagnosis and treatment of tumours | |
GB0320238D0 (en) | Treatment of disease | |
AU2003293099A8 (en) | Treatment of dna damage related disorders | |
EP1651237A4 (en) | METHOD FOR THE TREATMENT OF DERMATOLOGICAL ILLNESSES | |
EP1624786A4 (en) | METHOD FOR THE TREATMENT AND PREVENTION OF ILLNESSES OF BIOLOGICAL CHANNELS | |
GB0211295D0 (en) | Treatment of pain | |
GB0306309D0 (en) | Method of treatment | |
AU2003259833A8 (en) | Methods of treating neurodegenerative diseases | |
GB0302572D0 (en) | Method of treatment | |
GB0210741D0 (en) | Methods of therapy | |
GB0422634D0 (en) | Method of treating skin diseases | |
GB0217493D0 (en) | Novel methods of treatment | |
EP1552012A4 (en) | PREDISPOSITION GENE FOR ATTACK IN HUMANS AND METHODS OF TREATMENT | |
GB0208897D0 (en) | New method of treatment | |
GB0221712D0 (en) | Methods of treatment | |
AU2003270615A8 (en) | Treatment of steatosis using hyperthermia | |
AU2003252188A8 (en) | Method of ore treatment | |
EP1483407A4 (en) | THERAPY AND DIAGNOSTIC PROCEDURES | |
GB0327975D0 (en) | Methods of treatment | |
GB0213198D0 (en) | Method of treatment | |
AU2003293581A8 (en) | Method of identifying therapeutic agents | |
EP1567863A4 (en) | METHODS OF THERAPY AND DIAGNOSIS | |
GB0207091D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050418 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060425 |
|
17Q | First examination report despatched |
Effective date: 20060904 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GULCHER, JEFFREY, R. Inventor name: THORLEIFSSON, GUDMAR Inventor name: REYNISDOTTIR, SIGRIDUR, TH. Inventor name: GRETARSDOTTIR, SOLVEIG |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GULCHER, JEFFREY, R. Inventor name: THORLEIFSSON, GUDMAR Inventor name: REYNISDOTTIR, SIGRIDUR, TH. Inventor name: GRETARSDOTTIR, SOLVEIG |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080925 |